These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 37940956)

  • 21. Polymorphisms in genes associated with drug resistance of Plasmodium vivax in India.
    Anantabotla VM; Antony HA; Parija SC; Rajkumari N; Kini JR; Manipura R; Nag VL; Gadepalli R; Chayani N; Patro S
    Parasitol Int; 2019 Jun; 70():92-97. PubMed ID: 30836136
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Assessing the in vitro sensitivity with associated drug resistance polymorphisms in Plasmodium vivax clinical isolates from Delhi, India.
    Matlani M; Kumar A; Singh V
    Exp Parasitol; 2021 Jan; 220():108047. PubMed ID: 33221328
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevalence and patterns of antifolate and chloroquine drug resistance markers in Plasmodium vivax across Pakistan.
    Khattak AA; Venkatesan M; Khatoon L; Ouattara A; Kenefic LJ; Nadeem MF; Nighat F; Malik SA; Plowe CV
    Malar J; 2013 Sep; 12():310. PubMed ID: 24007534
    [TBL] [Abstract][Full Text] [Related]  

  • 24. No Association between the Plasmodium vivax
    Rumaseb A; Moraes Barros RR; Sá JM; Juliano JJ; William T; Braima KA; Barber BE; Anstey NM; Price RN; Grigg MJ; Marfurt J; Auburn S
    Antimicrob Agents Chemother; 2023 Jul; 67(7):e0161022. PubMed ID: 37314336
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prediction of the CYP2D6 enzymatic activity based on investigating of the CYP2D6 genotypes around the vivax malaria patients in Yunnan Province, China.
    Dong Y; Huang H; Deng Y; Xu Y; Chen M; Liu Y; Zhang C
    Malar J; 2021 Nov; 20(1):448. PubMed ID: 34823523
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression and function of pvcrt-o, a Plasmodium vivax ortholog of pfcrt, in Plasmodium falciparum and Dictyostelium discoideum.
    Sá JM; Yamamoto MM; Fernandez-Becerra C; de Azevedo MF; Papakrivos J; Naudé B; Wellems TE; Del Portillo HA
    Mol Biochem Parasitol; 2006 Dec; 150(2):219-28. PubMed ID: 16987557
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Plasmodium vivax chloroquine resistance links to pvcrt transcription in a genetic cross.
    Sá JM; Kaslow SR; Moraes Barros RR; Brazeau NF; Parobek CM; Tao D; Salzman RE; Gibson TJ; Velmurugan S; Krause MA; Melendez-Muniz V; Kite WA; Han PK; Eastman RT; Kim A; Kessler EG; Abebe Y; James ER; Chakravarty S; Orr-Gonzalez S; Lambert LE; Engels T; Thomas ML; Fasinu PS; Serre D; Gwadz RW; Walker L; DeConti DK; Mu J; Bailey JA; Sim BKL; Hoffman SL; Fay MP; Dinglasan RR; Juliano JJ; Wellems TE
    Nat Commun; 2019 Sep; 10(1):4300. PubMed ID: 31541097
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular surveillance for drug resistance markers in Plasmodium vivax isolates from symptomatic and asymptomatic infections at the China-Myanmar border.
    Zhao Y; Wang L; Soe MT; Aung PL; Wei H; Liu Z; Ma T; Huang Y; Menezes LJ; Wang Q; Kyaw MP; Nyunt MH; Cui L; Cao Y
    Malar J; 2020 Aug; 19(1):281. PubMed ID: 32758218
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevalence of drug resistance-associated gene mutations in Plasmodium vivax in Central China.
    Lu F; Wang B; Cao J; Sattabongkot J; Zhou H; Zhu G; Kim K; Gao Q; Han ET
    Korean J Parasitol; 2012 Dec; 50(4):379-84. PubMed ID: 23230341
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Surveillance of drug resistance molecular markers in Plasmodium vivax before and after introduction of dihydroartemisinin and piperaquine in Thailand: 2009-2019.
    Suphakhonchuwong N; Rungsihirunrat K; Kuesap J
    Parasitol Res; 2023 Dec; 122(12):2871-2883. PubMed ID: 37725258
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Therapeutic efficacy of pyronaridine-artesunate (Pyramax) in treating
    Manh ND; Thanh NV; Quang HH; Van NTT; San NN; Phong NC; Birrell GW; Edgel KA; Martin NJ; Edstein MD; Chavchich M
    Antimicrob Agents Chemother; 2024 Sep; 68(9):e0004424. PubMed ID: 39046237
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical and molecular surveillance of drug resistant vivax malaria in Myanmar (2009-2016).
    Nyunt MH; Han JH; Wang B; Aye KM; Aye KH; Lee SK; Htut Y; Kyaw MP; Han KT; Han ET
    Malar J; 2017 Mar; 16(1):117. PubMed ID: 28298235
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High Proportion of Genome-Wide Homology and Increased Pretreatment
    Rovira-Vallbona E; Van Hong N; Kattenberg JH; Huan RM; Binh NTH; Ngọc NTH; Guetens P; Hieu NL; Hien NTT; Sang VT; Long ND; Sauve E; Duong TT; Xa NX; Erhart A; Rosanas-Urgell A
    Antimicrob Agents Chemother; 2021 Jul; 65(8):e0009521. PubMed ID: 34031050
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular detection of drug resistant malaria in Southern Thailand.
    Noisang C; Prosser C; Meyer W; Chemoh W; Ellis J; Sawangjaroen N; Lee R
    Malar J; 2019 Aug; 18(1):275. PubMed ID: 31416468
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genetic polymorphism in pvmdr1 and pvcrt-o genes in relation to in vitro drug susceptibility of Plasmodium vivax isolates from malaria-endemic countries.
    Lu F; Lim CS; Nam DH; Kim K; Lin K; Kim TS; Lee HW; Chen JH; Wang Y; Sattabongkot J; Han ET
    Acta Trop; 2011 Feb; 117(2):69-75. PubMed ID: 20933490
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Active case detection, treatment of falciparum malaria with combined chloroquine and sulphadoxine/pyrimethamine and vivax malaria with chloroquine and molecular markers of anti-malarial resistance in the Republic of Vanuatu.
    Kinzer MH; Chand K; Basri H; Lederman ER; Susanti AI; Elyazar I; Taleo G; Rogers WO; Bangs MJ; Maguire JD
    Malar J; 2010 Apr; 9():89. PubMed ID: 20370920
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular epidemiology of potential candidate markers for chloroquine resistance in imported Plasmodium vivax malaria cases in Iran.
    Pirahmadi S; Afzali S; Mehrizi AA; Raz A; Raeisi A
    Malar J; 2023 Apr; 22(1):118. PubMed ID: 37038137
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Longitudinal ex vivo and molecular trends of chloroquine and piperaquine activity against Plasmodium falciparum and P. vivax before and after introduction of artemisinin-based combination therapy in Papua, Indonesia.
    Marfurt J; Wirjanata G; Prayoga P; Chalfein F; Leonardo L; Sebayang BF; Apriyanti D; Sihombing MAEM; Trianty L; Suwanarusk R; Brockman A; Piera KA; Luo I; Rumaseb A; MacHunter B; Auburn S; Anstey NM; Kenangalem E; Noviyanti R; Russell B; Poespoprodjo JR; Price RN
    Int J Parasitol Drugs Drug Resist; 2021 Dec; 17():46-56. PubMed ID: 34193398
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Analysis of single-nucleotide polymorphisms in the crt-o and mdr1 genes of Plasmodium vivax among chloroquine-resistant isolates from the Brazilian Amazon region.
    Orjuela-Sánchez P; de Santana Filho FS; Machado-Lima A; Chehuan YF; Costa MR; Alecrim Md; del Portillo HA
    Antimicrob Agents Chemother; 2009 Aug; 53(8):3561-4. PubMed ID: 19451296
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Polymorphism of 72-76 Coding Sequence within Exon 2 Region of Pfcrt in Yunnan Province].
    Zhu YJ; Chen MN; Xu YC; Mao XH; Deng Y; Dong Y
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2016 Jun; 34(3):227-32. PubMed ID: 30129722
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.